71. Rossello‐Urgell J, Vaque‐Rafart J, Hermosilla‐Perez E, Allepuz‐Palau A, Group EW. An approach to the study of potentially preventable nosocomial infections. Infect Control Hosp Epidemiol. 2004;25(1):41‐6 https://doi.org/10.1086/502290. 72. Umscheid CA, Mitchell MD, Doshi JA, Agarwal R, Williams K, Brennan PJ. Estimating the proportion of healthcare‐associated infections that are reasonably preventable and the related mortality and costs. Infect Control Hosp Epidemiol. 2011;32(2):101‐14 https://doi.org/10.1086/657912. 73. Schreiber PW, Sax H, Wolfensberger A, Clack L, Kuster SP, Swissnoso. The preventable proportion of healthcare‐associated infections 2005‐2016: Systematic review and meta‐analysis. Infect Control Hosp Epidemiol. 2018;39(11):1277‐95 https://doi.org/10.1017/ice.2018.183. 74. Bearman G, Doll M, Cooper K, Stevens MP. Hospital Infection Prevention: How Much Can We Prevent and How Hard Should We Try? Curr Infect Dis Rep. 2019;21(1):2 https://doi.org/10.1007/s11908‐019‐0660‐ 2. 75. Tabah A, Koulenti D, Laupland K, Misset B, Valles J, Bruzzi de Carvalho F, et al. Characteristics and determinants of outcome of hospital‐acquired bloodstream infections in intensive care units: the EUROBACT International Cohort Study. Intensive Care Med. 2012;38(12):1930‐45 https://doi.org/10.1007/s00134‐012‐2695‐9. 76. Kadri SS, Lai YL, Warner S, Strich JR, Babiker A, Ricotta EE, et al. Inappropriate empirical antibiotic therapy for bloodstream infections based on discordant in‐vitro susceptibilities: a retrospective cohort analysis of prevalence, predictors, and mortality risk in US hospitals. The Lancet infectious diseases. 2021;21(2):241‐51 https://doi.org/10.1016/S1473‐3099(20)30477‐1. 77. Rottier WC, Deelen JWT, Caruana G, Buiting AGM, Dorigo‐Zetsma JW, Kluytmans J, et al. Attributable mortality of antibiotic resistance in gram‐negative infections in the Netherlands: a parallel matched cohort study. Clin Microbiol Infect. 2020 https://doi.org/10.1016/j.cmi.2020.07.014. 78. Jong de A. Toiletten lijken de bron van de hardnekkige multiresistente NDM‐bacterie in het nog nieuwe Zaans Medisch Centrum. Dat zegt hoogleraar microbiologie Jan Kluytmans. Noordhollands Dagblad. 2019(1/6/2019). 79. Ministry of Public Health Welfare and Sport. Letter of the minister of Public Health, Welfare and Sport (nr 159) to the Chair of the Dutch Lower House of the States‐General. 32 620. Den Haag2015. 80. O' Neill J. TACKLING DRUG‐RESISTANT INFECTIONS GLOBALLY: FINAL REPORT AND RECOMMENDATIONS. Wellcome Trust and UK Government; 2016. 81. de Greeff S, Schoffelen AF, Verduin CM. Nethmap (Consumption of antimicrobial agents and antimicrobial resistance among medically important bacteria in the Netherlands in 2019). Dutch Foundation of the Working Party on Antibiotic Policy, Centre for Infectious disease control (National Institute for Public Health and the Environment of the Netherlands); 2020. 82. de Greeff S, Kolwijck E, Schoffelen AF, Verduin CM. Nethmap (Consumption of antimicrobial agents and antimicrobial resistance among medically important bacteria in the Netherlands in 2021). Dutch Foundation of the Working Party on Antibiotic Policy, Centre for Infectious disease control (National Institute for Public Health and the Environment of the Netherlands); 2022. 83. Stone MJ, Swales C, Bond SE, Muthayya P, Sarma JB. An outbreak of livestock‐associated meticillin‐ resistant Staphylococcus aureus (LA‐MRSA) clonal complex 398 in a regional burns centre. J Hosp Infect. 2022;122:1‐8 https://doi.org/10.1016/j.jhin.2021.12.005. 84. Landelijke Coördinatie Infectieziektenbestrijding (LCI). Refugees Ukraine and infectious diseases (Vluchtelingen Oekraïne en infectieziekten) 2022 [updated 01‐06‐2022. Available from: https://lci.rivm.nl/richtlijnen/vluchtelingenoekraine#:~:text=Volgens%20beperkte%20beschikbare%20gege 10 257 General Discussion
RkJQdWJsaXNoZXIy MTk4NDMw